Capital Markets Advisory: 2020 Year in Review

Despite the impact of the pandemic, 2020 was a record year for the U.

More

SPAC Mergers Are a Popular (and Accelerated)
Way to Go Public

SPACs became ever more popular through 2020 and 2021, with SPAC IPOs raising more than $245 billion over the past two years.

More

How to Mitigate the Cheap Stock Issue When Preparing for an IPO

When a company embarks on an initial public offering (IPO), one of the most significant challenges in the registration process with the U.

More

Olema Pharmaceuticals Closes $209 Million Initial Public Offering with Support from CFGI

CFGI’s Capital Markets team supported Olema Pharmaceuticals (Nasdaq: OLMA) with an initial public offering of 11,000,000 shares of common stock priced at $19.

More

The Future Is Already Here, and CFOs Need to Transform Finance to Survive

Download the Whitepaper

Vital Farms Closes $111 Million Initial Public Offering with Support from CFGI

CFGI’s Capital Markets team supported Vital Farms (Nasdaq: VITL) with an initial public offering of 5,040,323 shares of common stock priced at $22.

More

Case Study: Initial Public Offering of Foreign Medical Diagnostic Company

Case Study: Initial Public Offering of a Clinical Stage Biotech

Whitepaper: To IPO, or not to IPO, that is the question

This paper explores the current regulatory environment, market trends, the preparation necessary to ensure readiness, as well as the transition and long-term effects of becoming a public company.

More